Hand foot skin reaction (HFSR) by the multikinase inhibitors (MKIs) sorafenib and sunitinib: Impact on quality of life (QoL)
| Autor: | R. H. Huggins, Timothy M. Kuzel, Dennis P. West, Mario E. Lacouture, Roger T. Anderson |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
Sorafenib
Oncology Cancer Research medicine.medical_specialty Sunitinib business.industry urologic and male genital diseases female genital diseases and pregnancy complications Surgery Multikinase inhibitor Skin reaction Quality of life Internal medicine medicine Survival advantage business Foot (unit) medicine.drug |
| Zdroj: | Journal of Clinical Oncology. 26:16122-16122 |
| ISSN: | 1527-7755 0732-183X |
| DOI: | 10.1200/jco.2008.26.15_suppl.16122 |
| Popis: | 16122 Background: The MKIs sorafenib and sunitinib have shown a survival advantage in a variety of solid tumors. However, their use is hampered by the occurrence of HFSR in 20–30% of patients (pts)... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|